Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

291.46
-1.9750-0.67%
Volume:75.95K
Turnover:22.24M
Market Cap:156.72B
PE:26.63
High:293.40
Open:293.21
Low:291.18
Close:293.43
Loading ...

This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life. -- Barrons.com

Dow Jones
·
15 Apr

UBS Adjusts Amgen Price Target to $319 From $315, Maintains Neutral Rating

MT Newswires Live
·
14 Apr

Amgen Facing US Antitrust Lawsuit Filed by Sandoz

MT Newswires Live
·
14 Apr

Sandoz files antitrust litigation against Amgen regarding Enbrel

TIPRANKS
·
14 Apr

Sandoz Files Antitrust Lawsuit Against Amgen Over Enbrel Market Dominance

TIPRANKS
·
14 Apr

Switzerland's Sandoz files antitrust lawsuit against Amgen in US

Reuters
·
14 Apr

BRIEF-Sandoz Files Antitrust Litigation Against Amgen In The US

Reuters
·
14 Apr

Sandoz Files Antitrust Litigation Against Amgen Regarding Patient Access to Etanercept Biosimilar in the US

THOMSON REUTERS
·
14 Apr

Sandoz Group Ag - Seeks Triple Damages in Antitrust Lawsuit

THOMSON REUTERS
·
14 Apr

Sandoz Group Ag - Alleges Amgen Blocked Biosimilar Competition

THOMSON REUTERS
·
14 Apr

Amgen Has A Growth Plan in Its Pocket. Buy The Stock. -- Barron's

Dow Jones
·
12 Apr

Amgen (AMGN) Gains But Lags Market: What You Should Know

Zacks
·
12 Apr

Amgen Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
12 Apr

Amgen (NasdaqGS:AMGN) Clinical Trial Success In SCLC Treatment With IMDELLTRA

Simply Wall St.
·
12 Apr

Citigroup Adjusts Price Target on Amgen to $290 From $295, Keeps Neutral Rating

MT Newswires Live
·
11 Apr

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live
·
11 Apr

BRIEF-Imdelltra® Demonstrated Superior Overall Survival In Small Cell Lung Cancer

Reuters
·
11 Apr

Amgen Says Phase 3 Trial of Lung Cancer Drug Imdelltra Met Primary Endpoint at Interim

MT Newswires Live
·
11 Apr

Amgen Inc: Global Phase 3 Dellphi-304 Clinical Trial Met Its Primary Endpoint at a Planned Interim Analysis

THOMSON REUTERS
·
11 Apr

Amgen: Imdelltra Showed Statistically Significant and Clinically Meaningful Improvement in Os VS Local Standard-of-Care Chemotherapy

THOMSON REUTERS
·
11 Apr